We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Hudbay
HBM
$10.5B
| $1.39M | 0.42% |
+58,997
| New | +$1.49M |
2026 Q2
0 quarters
|
|
52
CMB.TECH NV
CMBT
$5.14B
| $1.37M | 0.41% |
97,131
-13,979
| -13% | -$201K |
2025 Q4
2 quarters
|
|
53
Golar LNG
GLNG
$4.64B
| $1.33M | 0.4% |
+26,743
| New | +$1.41M |
2026 Q2
0 quarters
|
|
54
Relay Therapeutics
RLAY
$3.64B
| $1.32M | 0.39% |
70,693
+54,335
| +332% | +$789K |
2026 Q1
1 quarter
|
|
55
Novo Nordisk
NVO
$170B
| $1.23M | 0.37% |
25,600
+21,915
| +595% | +$942K |
2026 Q1
1 quarter
|
|
56
Equinox Gold
EQX
$12.9B
| $1.2M | 0.36% |
123,426
+3,659
| +3% | +$47.2K |
2024 Q4
6 quarters
|
|
57
DigitalOcean
DOCN
$11.5B
| $1.19M | 0.35% |
+7,550
| New | +$1.02M |
2026 Q2
0 quarters
|
|
58
Shopify
SHOP
$222B
| $1.14M | 0.34% |
+10,000
| New | +$1.14M |
2026 Q2
0 quarters
|
|
59
Corvus Pharmaceuticals
CRVS
$809M
| $1.12M | 0.33% |
74,796
+12,745
| +21% | +$177K |
2026 Q1
1 quarter
|
|
60
Similarweb
SMWB
$755M
| $1.1M | 0.33% |
180,000
| – | – |
2025 Q4
2 quarters
|
|
61
Okeanis Eco Tankers
ECO
$3.58B
| $1.1M | 0.33% |
+22,187
| New | +$1.16M |
2026 Q2
0 quarters
|
|
62
CALL
Kymera Therapeutics
KYMR
$8.77B
| $1.02M | 0.31% |
+381
| New | +$32.7K |
2026 Q2
0 quarters
|
|
63
Indivior Pharmaceuticals
INDV
$3.87B
| $1.02M | 0.31% |
24,934
+6,922
| +38% | +$251K |
2025 Q3
3 quarters
|
|
64
Centerra Gold
CGAU
$4.29B
| $1.01M | 0.3% |
+63,481
| New | +$1.11M |
2026 Q2
0 quarters
|
|
65
Invesco S&P 500 Equal Weight ETF
RSP
$98.7B
| $993K | 0.3% |
+4,667
| New | +$955K |
2026 Q2
0 quarters
|
|
66
CALL
uniQure
QURE
$1.51B
| $983K | 0.29% |
596
-44
| -7% | -$1.15K |
2026 Q1
1 quarter
|
|
67
Zymeworks
ZYME
$1.81B
| $939K | 0.28% |
35,935
| – | – |
2025 Q4
2 quarters
|
|
68
BioAge Labs
BIOA
$222M
| $913K | 0.27% |
37,253
+22,086
| +146% | +$399K |
2025 Q4
2 quarters
|
|
69
Taysha Gene Therapies
TSHA
$1.22B
| $909K | 0.27% |
+133,411
| New | +$789K |
2026 Q2
0 quarters
|
|
70
Vaxcyte
PCVX
$10.1B
| $878K | 0.26% |
15,105
+9,786
| +184% | +$532K |
2024 Q4
6 quarters
|
|
71
Coupang
CPNG
$25.7B
| $870K | 0.26% |
+50,064
| New | +$904K |
2026 Q2
0 quarters
|
|
72
CALL
SELLAS Life Sciences
SLS
$2.09B
| $853K | 0.25% |
1,013
+255
| +34% | +$1.76K |
2025 Q2
4 quarters
|
|
73
Canadian Solar
CSIQ
$636M
| $851K | 0.25% |
53,113
+3,113
| +6% | +$49.9K |
2026 Q1
1 quarter
|
|
74
Power Solutions International
PSIX
$1.11B
| $850K | 0.25% |
21,864
+17,569
| +409% | +$966K |
2026 Q1
1 quarter
|
|
75
Monte Rosa Therapeutics
GLUE
$840M
| $825K | 0.25% |
34,083
-13,417
| -28% | -$254K |
2025 Q4
2 quarters
|
|
Similar funds
JWM
PI
TFA
SIM
OWM
SS
BIA
TODC
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.